Patents by Inventor Anna Kotsakis Ruehlmann

Anna Kotsakis Ruehlmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR)
    Publication number: 20230414647
    Abstract: The present invention is directed to methods for the use of 5?-adenosine diphosphate ribose (ADPR), and compositions thereof, for treating, managing, or preventing RNA virus-related diseases or conditions, herpes virus related diseases or conditions, Sirtuin 6 (Sirt6)-related diseases or conditions, Pax6 related diseases or conditions, and p53 related diseases or conditions.
    Type: Application
    Filed: September 11, 2023
    Publication date: December 28, 2023
    Applicant: Invirsa, Inc.
    Inventors: Robert Shalwitz, Anna Kotsakis Ruehlmann
  • Methods for the use of 5?-adenosine diphosphate ribose (ADPR)
    Patent number: 11793826
    Abstract: The present invention is directed to methods for the use of 5?-adenosine diphosphate ribose (ADPR), and compositions thereof, for treating, managing, or preventing RNA virus-related diseases or conditions, herpes virus related diseases or conditions, Sirtuin 6 (Sirt6)-related diseases or conditions, Pax6 related diseases or conditions, and p53 related diseases or conditions.
    Type: Grant
    Filed: February 9, 2021
    Date of Patent: October 24, 2023
    Assignee: Invirsa, Inc.
    Inventors: Robert Shalwitz, Anna Kotsakis Ruehlmann
  • METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR)
    Publication number: 20210161936
    Abstract: The present invention is directed to methods for the use of 5?-adenosine diphosphate ribose (ADPR), and compositions thereof, for treating, managing, or preventing RNA virus-related diseases or conditions, herpes virus related diseases or conditions, Sirtuin 6 (Sirt6)-related diseases or conditions, Pax6 related diseases or conditions, and p53 related diseases or conditions.
    Type: Application
    Filed: February 9, 2021
    Publication date: June 3, 2021
    Applicant: Invirsa, Inc.
    Inventors: Robert Shalwitz, Anna Kotsakis Ruehlmann
  • METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR)
    Publication number: 20190298752
    Abstract: The present invention is directed to methods for the use of 5?-adenosine diphosphate ribose (ADPR), and compositions thereof, for treating, managing, or preventing RNA virus-related diseases or conditions, herpes virus related diseases or conditions, Sirtuin 6 (Sirt6)-related diseases or conditions, Pax6 related diseases or conditions, and p53 related diseases or conditions.
    Type: Application
    Filed: March 26, 2019
    Publication date: October 3, 2019
    Applicant: Invirsa, Inc.
    Inventors: Robert Shalwitz, Anna Kotsakis Ruehlmann